At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen Lachmann, MA, MB BChir, MD, FRCP, from the Royal Free London NHS Foundation Trust, London, UK, talks about the rare tumour necrosis factor receptor-associated periodic syndrome (TRAPS), and the strategies that are available for controlling and treating this condition.
>